Interleukin 21 – its potential role in the therapy of B-cell lymphomas
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin 21 – its potential role in the therapy of B-cell lymphomas
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 58, Issue 1, Pages 17-29
Publisher
Informa UK Limited
Online
2016-07-13
DOI
10.1080/10428194.2016.1201568
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma
- (2015) S. Bhatt et al. BLOOD
- Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
- (2015) Joan Montero et al. CELL
- IL-21 Stimulates Human Myeloma Cell Growth through an Autocrine IGF-1 Loop
- (2014) E. Menoret et al. JOURNAL OF IMMUNOLOGY
- Antibody-Cytokine Fusion Proteins for Treatment of Cancer: Engineering Cytokines for Improved Efficacy and Safety
- (2014) Patricia A. Young et al. SEMINARS IN ONCOLOGY
- Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study
- (2014) Shailender Bhatia et al. Journal for ImmunoTherapy of Cancer
- CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma
- (2013) S. Bhatt et al. BLOOD
- EBV counteracts IL-21-induced apoptosis in an EBV-positive diffuse large B-cell lymphoma cell line
- (2013) Liang Wu et al. INTERNATIONAL JOURNAL OF CANCER
- Interleukin-21 Enhances Rituximab Activity in a Cynomolgus Monkey Model of B Cell Depletion and in Mouse B Cell Lymphoma Models
- (2013) Cecile M. Krejsa et al. PLoS One
- A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer
- (2012) N Steele et al. BRITISH JOURNAL OF CANCER
- A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders
- (2012) J. M. Timmerman et al. CLINICAL CANCER RESEARCH
- Interleukin-21 Has Activity in Patients With Metastatic Melanoma: A Phase II Study
- (2012) Teresa M. Petrella et al. JOURNAL OF CLINICAL ONCOLOGY
- Abundant expression of interleukin-21 receptor in follicular lymphoma cells is associated with more aggressive disease
- (2012) Brianne Wood et al. LEUKEMIA & LYMPHOMA
- A Phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC)
- (2010) Viktor Grünwald et al. ACTA ONCOLOGICA
- Safety and Clinical Effect of Subcutaneous Human Interleukin-21 in Patients with Metastatic Melanoma or Renal Cell Carcinoma: A Phase I Trial
- (2010) H. Schmidt et al. CLINICAL CANCER RESEARCH
- A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1-Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages
- (2010) B. E. Wahlin et al. CLINICAL CANCER RESEARCH
- Heterogeneous expression and function of IL-21R and susceptibility to IL-21−mediated apoptosis in follicular lymphoma cells
- (2010) Daniela de Totero et al. EXPERIMENTAL HEMATOLOGY
- Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non-Hodgkin's lymphoma
- (2010) Mehmood H Hashmi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A Fusion of GMCSF and IL-21 Initiates Hypersignaling Through the IL-21Rα Chain With Immune Activating and Tumoricidal Effects In Vivo
- (2010) Patrick Williams et al. MOLECULAR THERAPY
- IL-21 Contributes to JAK3/STAT3 Activation and Promotes Cell Growth in ALK-Positive Anaplastic Large Cell Lymphoma
- (2009) Jennifer Dien Bard et al. AMERICAN JOURNAL OF PATHOLOGY
- Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas
- (2009) K. A. Sarosiek et al. BLOOD
- Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial
- (2009) I. D. Davis et al. CLINICAL CANCER RESEARCH
- Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism
- (2009) P Gelebart et al. LEUKEMIA
- IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis
- (2008) F. A. Scheeren et al. BLOOD
- IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro
- (2008) A. Gowda et al. BLOOD
- Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteins
- (2008) Michael G. Dodds et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Effective collaboration between IL-4 and IL-21 on B cell activation
- (2008) T SAITO et al. IMMUNOBIOLOGY
- Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma
- (2008) John A. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin 21: combination strategies for cancer therapy
- (2008) Kresten Skak et al. NATURE REVIEWS DRUG DISCOVERY
- The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways
- (2007) D. de Totero et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation